Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- article scientifique publié en 2016 (fr)
- наукова стаття, опублікована у квітні 2016 (uk)
- scientific article published on 12 April 2016 (en)
- 2016 թվականի ապրիլի 12-ին հրատարակված գիտական հոդված (hy)
- artículu científicu espublizáu n'abril de 2016 (ast)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Wei Zhu
- Chun-Mei Li
- Zhen-Zhen Ge
- Rong-Zu Nie
|
rdfs:label
| - A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (en)
- A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (nl)
|
skos:prefLabel
| - A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (en)
- A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (nl)
|
name
| - A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (en)
- A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (nl)
|
author
| |
author
| |
title
| |
title
| - A-type dimeric epigallocatechin-3-gallate (EGCG) is a more potent inhibitor against the formation of insulin amyloid fibril than EGCG monomer (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
volume
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/J.BIOCHI.2016.03.011
|
is about
of | |
is cites work
of | |
is cites work
of | |